Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-23-016104
Filing Date
2023-12-06
Accepted
2023-12-06 17:04:52
Documents
1
Period of Report
2023-11-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-63726.html 4  
1 PRIMARY DOCUMENT marketforms-63726.xml 4 33222
  Complete submission text file 0001214659-23-016104.txt   34574
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Issuer) CIK: 0001087294 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2525 WEST END AVENUE, SUITE 950 NASHVILLE TN 37203
Business Address
Young Caroline (Reporting) CIK: 0001684087 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33637 | Film No.: 231470395